Here we discuss these alterations at the level of brain regions, brain cells, and brain membrane and cytoskeletal proteins with an special focus in NMDA molecular changes through aging and its effect in cognitive decline and Alzheimer disease. The gene discussed is DNM2; the disease is early-onset autosomal dominant Alzheimer disease.